Other | Biotech Company
This is an invention that encapsulate proteins. The advantages are:
1. Stabilization of biological molecules that remain functional for at least 20 cycles of reaction => encapsulation process RESPECT the configuration of antibodies, antigens, enzymes.
2. Capacity of carrying different biological molecules in an independent format; e.g. besides mono-enzymatic this composite can work as a catalytic-cascade support: different enzymes can be encapsulated separately and at the same time.
3. Encapsulated proteins gain denaturation-resistance and the robustness of the composite enable its intensive use in:
►Medical Diagnosis Devices - encapsulated antibodies or antigens, in which the composite is permeated by a liquid biological sample and the counterparts’ antigens (or antibodies) or biomarkers from the donner patient are detected.
►Biocatalysis - encapsulated enzymes are advantageous over soluble enzymes => no need for continuous replacement of the enzymes, easier separation from the products, higher stability under industrial harsh conditions.
This is a profitably invention because:
a)- Point-of-Care Test (POCT) market in 2011 was in the order of USD 15 billion. The registration was in 2017 of 23 billion USD and a market growth rate around 10% per annum. Projection of the global POCTs market for 2022: USD 38 billion.
b)- Biocatalysis use enzymes for manufacturing products of high commercial value in fine chemicals, pharmaceuticals and agrochemical intermediates, besides traditional applications in food industry. Enzymes are widely relevant in industrial budgets.
This invention that is under international patent: the novelty, inventive step and industrial application of all claims were fully recognized before IP international registration request, and that complied not only the method to synthetize both composites but the final product as well.
COROLARIUM: we intend to market this invention.
Other | Healthcare Provider
The HPA Health Group provides medical support throughout the Algarve, Alentejo and Madeira island and operating since 1996.
It is a reference in private health care in the Algarve region.
In addition to the healthcare units, the HPA Health Group includes other companies such as ambulance services, parapharmacies, clinical analysis laboratories, imaging and cardiovascular intervention centers.
It consists of six hospital units: Hospital Particular do Algarve - Alvor 24H, Hospital Particular do Algarve - Gambelas - Faro 24H; Hospital de São Camilo – Portimão; Hospital São Gonçalo de Lagos - Lagos, Hospital Particular do Alentejo - Sines and Hospital Particular da Madeira - Funchal 24H and Clinics in various parts of the Algarve, Alentejo and Madeira island.
Norte (Portugal) | Other
MyCareforce is a 100% digital platform that has a pool of +1400 nurses interested in being connected with available shifts in Healthcare Institutions.
Today was the Results Presentation Session* of the project CovidLearning - Knowledge sharing for health professionals. CovidLearning is a collaborative project combining AI-based solutions that allow accessing the latest scientific evidence and information related to SARS-CoV-2 and COVID-19, in order to improve the quality of information for health professionals, researchers and to the community. At search.covid-learning.com you will have access to a qualitative analysis of scientific articles, produced by machine-learning algorithms and based on widely accepted criteria.If you want to know more about the project go to www.covid-learning.com.Partners:iCognitus4ALL - IT SolutionsCentro de Medicina Digital P5ICVS - Life and Health Sciences Research InstituteCINTESIS - Center for Health Technology and Services Research/Faculdade de Medicina da Universidade do PortoHealth Cluster PortugalThis project (No. 65157/NORTE-01-02B7-FEDER-065157) was financed by NORTE 2020, through the European Structural and Investment Funds, within the scope of SI I&D Empresas - COVID-19.*The recording of the session will be soon available on the Health Cluster Portugal YouTube channel: https://lnkd.in/dHrZGpu
Generic demands for unmet needs | Other
IVD Portugal is a plastic injection molding company based in Coruche. Our Mission is to provide medical devices and products with the highest quality according to MD specification ISO 13485; Directive 93/42 & 98/79 and Regulation 745/2017 & 746/2017. Our customer focus are: B2B partnerships; Company consortium for new product developments; Laboratories and Hospitals.
Spring brings a new edition of JoinHealth organized by Health Cluster Portugal and EIT Health#JoinHealth Spring Welcome Webinars | May and June | Tuesdays at 2:30pmThis edition will cover topics such as interoperability of data in health, preclinical research, sales, cybersecurity and more...Stay tuned to the topics and dates at www.healthportugal.com.
Other | Contract Manufacturing Organisation
IVD Portugal is a plastic injection moulding company based in Coruche.
Our Mission is to provide medical devices and products with the highest quality according to MD specification ISO 13485; Directive 93/42 & 98/79 and Regulation 745/2017 & 746/2017.
Our costumer focus are :
- B2B partnerships;
- Company consortium for new product developments;
- Laboratories and Hospitals.
Other | Public / Nonprofit Organisation; Other
The China IP SME Helpdesk supports small and medium sized enterprises (SMEs) from European Union (EU) member states to protect and enforce their Intellectual Property Rights (IPR) in or relating to China, Hong Kong, Macao and Taiwan, through the provision of free information and services. The Helpdesk provides jargon-free, first-line, confidential advice on intellectual property and related issues, along with training events, materials and online resources. Individual SMEs and SME intermediaries can submit their IPR queries via email (firstname.lastname@example.org) and gain access to a panel of experts, in order to receive free and confidential first-line advice within 3 working days.
The China IP SME Helpdesk is an initiative by the European Union.
To learn more about the China IP SME Helpdesk and any aspect of intellectual property rights in China, please visit our online portal at https://ec.europa.eu/ip-helpdesk.
Norte (Portugal) | Contract Research Organisation; Laboratory / Analytical Services; R&D Institution
BnʼML - Behavioral & Molecular Lab is based in Braga, at the University of Minho and operates since 2012 in close association with the Institute for Research in Life and Health Sciences (ICVS). Its activities rely on the specialization and extensive research activity applied to the evaluation of the behavioral, cellular and molecular effects of drugs, in both in vitro and in vivo non-human models.Bn'ML's mission is to optimize the screening process for compounds of interest, in a preclinical phase, supporting the transition to the clinical trials phase. So, it provides services for behavioral, cellular and molecular analysis of the therapeutic potential of compounds.Bn’ML is also devoted to fundamental research that further sustains innovation in novel methods and technologies, based on the most recent advances and trends in the field. Moreover, Bn’ML is actively involved in education and training of graduate and postgraduate students, as a partner in the PhD program in Applied Health Sciences (University of Minho) and in providing short and long-term internships to students.The expertise of its team ranges from basic neuroscience, namely neural plasticity and neurophysiology, to applied preclinical research.